A mathematical and sensitivity analysis of an HIV/AIDS infection model
Author:
Ahmed Idris1, Tariboon Jessada2, Muhammad Mubarak3, Ibrahim Muhammad Jamilu1
Affiliation:
1. Department of Mathematics, Faculty of Natural and Applied Sciences , Sule Lamido University , Kafin Hausa , Jigawa State , Nigeria 2. Department of Mathematics, Faculty of Science , King Mongkut's University of Technology North Bangkok , Bangkok , , Thailand 3. Graduate School (Neurosience program) , Khon Kaen University , Khon Kaen , , Thailand
Abstract
Abstract
Over the past decade, Human Immunodeficiency Virus infection and Acquired Immunodeficiency Syndrome (HIV/AIDS) have become deadly infectious diseases, particularly in developing countries. This challenge has led to the development of some important HIV/AIDS treatment strategies, such as antiretroviral therapy (ART), among many others. This study presents a mathematical model to investigate the dynamics of HIV/AIDS transmission. Employing mathematical analysis, non-negativity, boundedness, the basic reproduction number ℛ
0, and the stability of both the disease-free and endemic equilibrium of the proposed model were derived. Normalized forward sensitivity techniques are used to determine the significance and importance of sensitive parameters associated with ℛ
0. To gain insights into the dynamical behavior of each compartment, an effective numerical scheme was utilized, and the results obtained suggest that there is a need, even if individuals are infected with the virus, to use non-pharmaceutical interventions as control strategies.
Publisher
Walter de Gruyter GmbH
Reference36 articles.
1. Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J., Wang B., Xiang H., Cheng Z., Xiong Y., Zhao Y., Li Y., Wang X., Peng A. Z., Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan/China, JAMA Network, 323(11), 1061–1069, 2020. 2. Reshadat-Hajiabad T., Khajavi A., Hosseinpour A.M., Bojdy A., Hashemi-Meshkini A., Varmaghani M., Determinants and economic burden of HIV/AIDS in Iran: a prospective study, BMC Health Services Research, 23(1), 251, 2023. 3. WHO, Chan M., Consolidated guidelines on “The use of Antiretroviral Drugs for Treating and Preventing HIV Infection” Recommendations for a Public Health Approach, (2nd Ed.), Switzerland, 1–480, 2016. 4. Easterbrook P., Johnson C., Figueroa C., Baggaley R., HIV and Hepatitis testing: global progress challenges and future directions, AIDS Reviews, 18(1), 3–14, 2016. 5. WHO, Chan M., Global health sector strategy on HIV 2016–2021, Switzerland, 1–60, 2016.
|
|